16 research outputs found
Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease.
Metabolic
profiling studies aim to achieve broad metabolome coverage
in specific biological samples. However, wide metabolome coverage
has proven difficult to achieve, mostly because of the diverse physicochemical
properties of small molecules, obligating analysts to seek multiplatform
and multimethod approaches. Challenges are even greater when it comes
to applications to tissue samples, where tissue lysis and metabolite
extraction can induce significant systematic variation in composition.
We have developed a pipeline for obtaining the aqueous and organic
compounds from diseased arterial tissue using two consecutive extractions,
followed by a different untargeted UPLC-MS analysis method for each
extract. Methods were rationally chosen and optimized to address the
different physicochemical properties of each extract: hydrophilic
interaction liquid chromatography (HILIC) for the aqueous extract
and reversed-phase chromatography for the organic. This pipeline can
be generic for tissue analysis as demonstrated by applications to
different tissue types. The experimental setup and fast turnaround
time of the two methods contributed toward obtaining highly reproducible
features with exceptional chromatographic performance (CV % < 0.5%),
making this pipeline suitable for metabolic profiling applications.
We structurally assigned 226 metabolites from a range of chemical
classes (e.g., carnitines, α-amino acids, purines, pyrimidines,
phospholipids, sphingolipids, free fatty acids, and glycerolipids)
which were mapped to their corresponding pathways, biological functions
and known disease mechanisms. The combination of the two untargeted
UPLC-MS methods showed high metabolite complementarity. We demonstrate
the application of this pipeline to cardiovascular disease, where
we show that the analyzed diseased groups (<i>n </i>= 120)
of arterial tissue could be distinguished based on their metabolic
profiles
TRY plant trait database – enhanced coverage and open access
Plant traits - the morphological, anatomical, physiological, biochemical and phenological characteristics of plants - determine how plants respond to environmental factors, affect other trophic levels, and influence ecosystem properties and their benefits and detriments to people. Plant trait data thus represent the basis for a vast area of research spanning from evolutionary biology, community and functional ecology, to biodiversity conservation, ecosystem and landscape management, restoration, biogeography and earth system modelling. Since its foundation in 2007, the TRY database of plant traits has grown continuously. It now provides unprecedented data coverage under an open access data policy and is the main plant trait database used by the research community worldwide. Increasingly, the TRY database also supports new frontiers of trait‐based plant research, including the identification of data gaps and the subsequent mobilization or measurement of new data. To support this development, in this article we evaluate the extent of the trait data compiled in TRY and analyse emerging patterns of data coverage and representativeness. Best species coverage is achieved for categorical traits - almost complete coverage for ‘plant growth form’. However, most traits relevant for ecology and vegetation modelling are characterized by continuous intraspecific variation and trait–environmental relationships. These traits have to be measured on individual plants in their respective environment. Despite unprecedented data coverage, we observe a humbling lack of completeness and representativeness of these continuous traits in many aspects. We, therefore, conclude that reducing data gaps and biases in the TRY database remains a key challenge and requires a coordinated approach to data mobilization and trait measurements. This can only be achieved in collaboration with other initiatives
A Survey of Aspirin Desensitization Practices Among Allergists and Fellows in Training in the United States
A survey of aspirin desensitization practices among allergists and fellows in training in the United States
Update on Aspirin Desensitization for Chronic Rhinosinusitis with Polyps in Aspirin-Exacerbated Respiratory Disease (AERD)
Predictive Factors of Reaction Severity during Standardized Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease (AERD).
Top-Down Systems Biology Modeling of Host Metabotype−Microbiome Associations in Obese Rodents
Covariation in the structural composition of the gut microbiome and the spectroscopically derived metabolic phenotype (metabotype) of a rodent model for obesity were investigated using a range of multivariate statistical tools. Urine and plasma samples from three strains of 10-week-old male Zucker rats (obese (fa/fa, n = 8), lean (fa/−, n = 8) and lean (−/−, n = 8)) were characterized via high-resolution 1H NMR spectroscopy, and in parallel, the fecal microbial composition was investigated using fluorescence in situ hydridization (FISH) and denaturing gradient gel electrophoresis (DGGE) methods. All three Zucker strains had different relative abundances of the dominant members of their intestinal microbiota (FISH), with the novel observation of a Halomonas and a Sphingomonas species being present in the (fa/fa) obese strain on the basis of DGGE data. The two functionally and phenotypically normal Zucker strains (fa/− and −/−) were readily distinguished from the (fa/fa) obese rats on the basis of their metabotypes with relatively lower urinary hippurate and creatinine, relatively higher levels of urinary isoleucine, leucine and acetate and higher plasma LDL and VLDL levels typifying the (fa/fa) obese strain. Collectively, these data suggest a conditional host genetic involvement in selection of the microbial species in each host strain, and that both lean and obese animals could have specific metabolic phenotypes that are linked to their individual microbiomes
Top-Down Systems Biology Modeling of Host Metabotype−Microbiome Associations in Obese Rodents
Covariation in the structural composition of the gut microbiome and the spectroscopically derived metabolic phenotype (metabotype) of a rodent model for obesity were investigated using a range of multivariate statistical tools. Urine and plasma samples from three strains of 10-week-old male Zucker rats (obese (fa/fa, n = 8), lean (fa/−, n = 8) and lean (−/−, n = 8)) were characterized via high-resolution 1H NMR spectroscopy, and in parallel, the fecal microbial composition was investigated using fluorescence in situ hydridization (FISH) and denaturing gradient gel electrophoresis (DGGE) methods. All three Zucker strains had different relative abundances of the dominant members of their intestinal microbiota (FISH), with the novel observation of a Halomonas and a Sphingomonas species being present in the (fa/fa) obese strain on the basis of DGGE data. The two functionally and phenotypically normal Zucker strains (fa/− and −/−) were readily distinguished from the (fa/fa) obese rats on the basis of their metabotypes with relatively lower urinary hippurate and creatinine, relatively higher levels of urinary isoleucine, leucine and acetate and higher plasma LDL and VLDL levels typifying the (fa/fa) obese strain. Collectively, these data suggest a conditional host genetic involvement in selection of the microbial species in each host strain, and that both lean and obese animals could have specific metabolic phenotypes that are linked to their individual microbiomes
